ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, published by WILEY, is a leading peer-reviewed journal dedicated to advancing the understanding of alcohol use and its clinical implications. With an impressive impact factor and categorized in the top quartile (Q1) in Medicine (miscellaneous), Psychiatry and Mental Health, and Toxicology, this journal serves a crucial role in disseminating high-quality research that informs clinical practice and health policy. The journal’s scope encompasses a wide range of topics related to alcohol use, including its effects on mental health, addiction, and public health, providing a vital platform for professionals, researchers, and students committed to enhancing knowledge in the field. The journal operates in the United States and is known for its rigorous editorial standards, ensuring that published articles contribute valuable insights to ongoing discussions in medicine and behavioral health. As of 2023-2024, the journal continues to thrive in a competitive academic landscape, aiming to foster collaboration and innovation in alcohol-related research.

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

Alkoholizm i Narkomania - Alcoholism and Drug Addiction is a prominent peer-reviewed journal published by the Institute of Psychiatry and Neurology, Department of Studies on Alcoholism in Warsaw, Poland. Renowned for its commitment to advancing the fields of addiction research and mental health, this journal disseminates critical findings regarding the prevention, treatment, and societal implications of alcoholism and drug addiction. Since becoming Open Access in 2017, it ensures that researchers, professionals, and students from across the globe have unrestricted access to valuable resources and emerging studies within this vital area of public health. The journal emphasizes innovative methodologies and interdisciplinary approaches, inviting contributions that explore the complex interplay of psychological, social, and biological factors influencing addiction. By fostering a collaborative and inclusive scholarly community, Alkoholizm i Narkomania aims to contribute significantly to the understanding and resolution of addiction-related challenges worldwide.

SLEEP MEDICINE, published by Elsevier, is a leading journal in the field of sleep research and clinical practice, dedicated to advancing the understanding of sleep disorders and their impact on health. With an impressive Q1 ranking in the Medicine (miscellaneous) category and a Scopus rank of #46 out of 636, this journal consistently demonstrates its significance within the academic community, showcasing research that spans the spectrum from basic science to clinical applications. The journal, which has been in publication since 2000, serves as a vital platform for clinicians, researchers, and students alike, offering insights into the latest findings in sleep medicine. Although it is not an open-access publication, SLEEP MEDICINE ensures comprehensive accessibility to high-quality scholarly content that addresses critical issues facing healthcare today, thereby contributing to improved patient care and outcomes.

Substance Abuse and Rehabilitation, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the study and treatment of substance abuse and related rehabilitation practices. With its ISSN 1179-8467, this journal provides a vital platform for researchers, clinicians, and students to disseminate their findings and insights in a field increasingly relevant to public health. Since becoming open access in 2010, the journal has enhanced its reach, allowing for a broader audience to engage with cutting-edge research and reviews that address the complexities of substance abuse disorders. The journal aims to foster innovation and interdisciplinary collaboration by publishing high-quality peer-reviewed articles that cover a wide range of topics, including addiction therapy, policy implications, and the social determinants of substance use. As a vital resource within the realm of addiction research, Substance Abuse and Rehabilitation plays a crucial role in driving forward knowledge and practices that can improve outcomes for individuals and communities affected by substance use issues.

Alcoholism Treatment Quarterly is a reputable journal dedicated to advancing the understanding of alcohol use disorders and their treatment. Published by Routledge Journals, Taylor & Francis Ltd, this journal has established itself as an essential resource within the fields of Medicine and Psychiatry and Mental Health, evidenced by its placement in the Q3 category for both disciplines in 2023. With a comprehensive scope covering the multifaceted aspects of alcoholism treatment, the journal serves as a vital platform for researchers, clinicians, and students to share and access high-quality, peer-reviewed articles. Although it is not an open-access journal, it is widely recognized for its contribution to the field, having been in continuous publication since 1984 and looking forward to its 40th anniversary in 2024. The journal aims to promote evidence-based practices and foster discourse on innovative treatment methods and research trends, making it an indispensable asset for anyone involved in the prevention and treatment of alcohol-related issues.

Substance Abuse: Research and Treatment is a premier open-access journal published by SAGE Publications Ltd, focusing on the multifaceted aspects of substance use and its impact on mental health. Since its establishment in 2008, this journal has been dedicated to disseminating innovative research findings, case studies, and reviews that enhance understanding and treatment of substance-related disorders. With an impact factor that reflects its standing in the field, currently ranked in the Q2 category of Psychiatry and Mental Health, Substance Abuse: Research and Treatment strives to foster interdisciplinary dialogue among researchers, practitioners, and students. By making its content freely accessible, the journal encourages widespread engagement and application of evidence-based practices to mitigate substance abuse issues. The journal’s diverse global perspectives make it a vital resource for anyone invested in advancing knowledge and improving treatment outcomes in this critical area of public health.

Adicciones is a prominent academic journal dedicated to the fields of Medicine and Psychiatry, focusing on the multi-faceted issues surrounding addiction and substance use. Published by SOCIDROGALCOHOL in Spain, this journal has been a critical resource for researchers, clinicians, and students since its inception in 1994, with a commitment to advancing knowledge in addiction science for the benefit of public health. With an impressive impact factor that places it in the Q3 category of both Medicine (Miscellaneous) and Psychiatry and Mental Health according to 2023 rankings, Adicciones is recognized for its high-quality peer-reviewed articles that contribute to the ongoing dialogue in these vital fields. Although not currently an open-access journal, it provides valuable subscription-based access to its extensive repository of research findings and reviews, fostering a deeper understanding of the complex dynamics of addiction. The journal's continued relevance is underscored by its convergence into 2024, promising ongoing contributions that inspire new ideas and practices to combat addiction.

Psychology of Addictive Behaviors, published by the Educational Publishing Foundation of the American Psychological Association, is a distinguished peer-reviewed journal dedicated to advancing the understanding of addiction through rigorous psychological research. With an impressive impact factor and a reputation for excellence, this journal holds a prestigious Q1 quartile ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health as of 2023. Since its inception in 1993, it has provided a vital platform for the dissemination of high-quality studies, fostering collaboration and knowledge exchange amidst researchers, clinicians, and students in the mental health arena. The journal is particularly noted for its comprehensive coverage of diverse topics related to addictive behaviors, thereby contributing significantly to the field's evidence base and clinical practices. Although currently not open access, its commitment to scholarly excellence ensures that subscribers benefit from invaluable insights into the complexities of addiction. With the culmination of research spanning from 1993 to 2024, Psychology of Addictive Behaviors stands as a cornerstone for those striving to understand and combat the challenges of addiction.

Behavioural Pharmacology is a distinguished academic journal published by Lippincott Williams & Wilkins, focusing on the intricate relationship between pharmacology, psychiatry, and behavioral science. With an ISSN of 0955-8810 and an E-ISSN of 1473-5849, this journal serves as a vital platform for researchers and professionals dedicated to exploring the pharmacological mechanisms underlying behavior and mental health. Operating with a robust track record since its inception in 1992, it has established itself in the academic community, as reflected by its Q3 rankings in both the pharmacology and psychiatry categories for 2023. Additionally, the journal holds a credible position in Scopus rankings, with a percentile ranking indicative of significant contributions to the fields of pharmacology and psychiatry. Aimed at advancing knowledge and disseminating research in the behavioral pharmacology domain, this journal is an essential resource for students, researchers, and clinical professionals seeking to stay at the forefront of this rapidly evolving field. While it is not an open access journal, the rich content and research findings published here continue to foster collaboration and innovation within the community, making it a crucial reference point for current and future studies.